AAAAAA

   
Results: 1-8 |
Results: 8
Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke - A Canadian healthcare perspective
Authors: Sinclair, SE Frighetto, L Loewen, PS Sunderji, R Teal, P Fagan, SC Marra, CA
Citation: Se. Sinclair et al., Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke - A Canadian healthcare perspective, PHARMACOECO, 19(9), 2001, pp. 927-936
Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme - A Canadian teaching hospital and ministry of health perspective
Authors: Wai, AO Frighetto, L Marra, CA Chan, E Jewesson, PJ
Citation: Ao. Wai et al., Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme - A Canadian teaching hospital and ministry of health perspective, PHARMACOECO, 18(5), 2000, pp. 451-457
Economic impact of standardized orders for antimicrobial prophylaxis program
Authors: Frighetto, L Marra, CA Stiver, HG Bryce, EA Jewesson, PJ
Citation: L. Frighetto et al., Economic impact of standardized orders for antimicrobial prophylaxis program, ANN PHARMAC, 34(2), 2000, pp. 154-160
A new ciprofloxacin stepdown program in the treatment of high-risk febrileneutropenia: A clinical and economic analysis
Authors: Marra, CA Frighetto, L Quaia, CB de Lemos, ML Warkentin, DI Marra, F Jewesson, PJ
Citation: Ca. Marra et al., A new ciprofloxacin stepdown program in the treatment of high-risk febrileneutropenia: A clinical and economic analysis, PHARMACOTHE, 20(8), 2000, pp. 933-942
Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes - A Canadian hospital perspective
Authors: Balen, RM Marra, CA Zed, PJ Cohen, M Frighetto, L
Citation: Rm. Balen et al., Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes - A Canadian hospital perspective, PHARMACOECO, 16(5), 1999, pp. 533-542
Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin
Authors: Yoshida, EM Erb, SR Partovi, N Scudamore, CH Chung, SW Frighetto, L Eggen, HJ Steinbrecher, UP
Citation: Em. Yoshida et al., Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin, LIVER TR S, 5(6), 1999, pp. 520-525
Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery
Authors: Frighetto, L Loewen, PS Dolman, J Marra, CA
Citation: L. Frighetto et al., Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery, CAN J ANAES, 46(6), 1999, pp. 536-543
Experience with ceftazidime parenteral-to-parenteral dosage stepdown in the empiric treatment of febrile neutropenia
Authors: Schwagly, N Frighetto, L MacDougall, C Jewesson, P
Citation: N. Schwagly et al., Experience with ceftazidime parenteral-to-parenteral dosage stepdown in the empiric treatment of febrile neutropenia, PHARMACOTHE, 19(5), 1999, pp. 641-647
Risultati: 1-8 |